More Business Wire
View Older Stories View Newer Stories-
Hotel Okura to Open The Okura Resort Hakone Gora in 2029
-
GoTyme Bank Launches Crypto Trading in the Philippines in Partnership with Alpaca
-
Edgewater Wireless Announces Completion of Eleventh and Twelfth Payments of Debenture Interest
-
Turnbull & Asser Appoints Roberto Menichetti as Creative Director
-
Gigaphoton Excimer Laser for Advanced Packaging Installed at Japanese Company
-
Sustainability Focus Session 2025
-
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
-
Panah Master Fund Counters M&A Capital Partners’ Rebuttal to its Previously Submitted Shareholder Proposals
-
Gartner Announces Gartner Finance Symposium/Xpo 2026 in Sydney
-
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
-
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
-
Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
-
Yescarta® Delivers Consistent Safety, Efficacy, and Quality of Life Benefits Across Broad Range of Relapsed/Refractory Large B-cell Lymphoma Patients in New Analysis at ASH 2025
-
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R²) in Patients with Relap
-
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future
-
Zai Lab Announces Updates to China’s National Reimbursement Drug List
-
Memphis Shines as Thousands Unite for St. Jude Memphis Marathon Weekend
-
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
-
Star Therapeutics Presents Interim Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease, Demonstrating Substantial Bleed Reductions in All Patients, at ASH Annual Meeting
-
TheOther Debuts Premium Matcha at an Intimate Art Basel Celebration in Miami Co-Hosted By Central Cee
-
Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma
-
Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025
-
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
-
Worthington Steel Issues Statement Regarding Klöckner & Co SE
-
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
-
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
-
Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting
-
NMDP℠ Demonstrates Scientific Leadership in Expanding Patient Access to Lifesaving Cell Therapy at ASH 2025
-
ReAlta Announces Promising Phase 2 Data Demonstrating Rapid Clinical Responses and Target Engagement in Steroid-Refractory Acute GvHD at the ASH 2025 Annual Meeting
-
Genetix Participates in the American Society of Hematology’s (ASH) Exclusive Press Program & Shares Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation
-
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
-
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies
-
DELETED: UFC Partners With Telegram for Exclusive Gift Drop This Weekend
-
Douglas Emmett Declares Quarterly Cash Dividend
-
KBRA Releases Research – Private Credit: Business Development Company (BDC) Ratings Compendium: Third-Quarter 2025 and 2026 Outlook
-
Lattice Wins 2025 Global Semiconductor Alliance Award
-
AMC Entertainment Holdings, Inc. Transfers the Majority of its Equity Investment in Hycroft Mining Holding Corporation to Sprott Mining for a Net Consideration of $24.1 million
-
Cyclum NextGen Travel Centers Continues with Phillips 66 for Historic Snowball Derby
-
“Karate Kid” Icon Ralph Macchio Reflects on Legacy With Sean Callagy—Blind Visionary, Speaker, and Influence Science Pioneer Poised to Become the First Self-Funded Blind Unicorn Founder During E
-
Emera Renews At-The-Market Equity Program
-
Carnegie Learning’s ClearMath Elementary Receives Perfect Scores from EdReports
-
Cohu to Participate in the 14th Annual NYC Summit Investor Conference
-
Birks Group Inc. Reports Mid-Year Fiscal 2026 Results
-
Comcast to Participate in UBS Investor Conference
-
Copper Property CTL Pass Through Trust Issues Monthly Reporting Package for November 2025
-
Ventas to Participate in Investor Meetings at Nareit’s REITworld 2025 Annual Conference
-
Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Scottsdale Promenade Welcomes The Elf on the Shelf®
-
Hamilton ETFs Announces Estimated 2025 Non-Cash Distributions
-
LibertyStream Announces Non-Brokered LIFE Offering Up to $10,000,000
